AI Verdict
LIND has stronger fundamentals based on our AI analysis.
LIPO vs LIND Fundamental Comparison
| Metric | LIPO | LIND |
|---|---|---|
| Revenue | $216,117.0 | $771.0M |
| Net Income | $-3.9M | $-29.7M |
| Net Margin | -1,799.1% | -3.9% |
| ROE | -261.4% | N/A |
| ROA | -165.5% | -3.0% |
| Current Ratio | 3.24x | 0.80x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-1.07 | $-0.63 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LIPO vs LIND: Frequently Asked Questions
Is LIPO or LIND a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LIND has stronger fundamentals. LIPO is rated STRONG SELL (90% confidence) while LIND is rated SELL (78% confidence). This is not investment advice.
How does LIPO compare to LIND fundamentally?
LIPELLA PHARMACEUTICALS INC. has ROE of -261.4% vs LINDBLAD EXPEDITIONS HOLDINGS, INC.'s N/A. Net margins are -1,799.1% vs -3.9% respectively.
Which stock pays higher dividends, LIPO or LIND?
LIPO has a dividend yield of N/A or no dividend while LIND has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LIPO or LIND for long term?
For long-term investing, consider that LIPO has STRONG SELL rating with 90% confidence, while LIND has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LIPO vs LIND?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LIPO vs LIND, the AI consensus favors LIND based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.